News & Updates
Filter by Specialty:
T2D treatment goal shifts from glucose centricity to end-organ protection
With the advent of disease-modifying agents such as tirzepatide, the current treatment goal for type 2 diabetes (T2D) extends beyond merely managing glycaemic levels to focusing on a broader approach that emphasizes end-organ protection.
T2D treatment goal shifts from glucose centricity to end-organ protection
28 May 2025
BP medication timing: Bedtime or daytime, the effect’s the same
For adults with hypertension being treated in the primary care setting, taking their blood pressure (BP)-lowering medications at bedtime is safe but confers no additional cardiovascular protection as opposed to taking them in the morning, according to the results of the BedMed trial.
BP medication timing: Bedtime or daytime, the effect’s the same
27 May 2025
Antiviral therapy lowers HCC risk in indeterminate CHB phase
Patients with chronic hepatitis B (CHB) in the indeterminate phase are predisposed to advanced liver disease and hepatocellular carcinoma (HCC), as shown by a systematic review and meta-analysis.
Antiviral therapy lowers HCC risk in indeterminate CHB phase
27 May 2025
MRI better at predicting long-term structural damage in early RA
In patients with early rheumatoid arthritis (RA), baseline MRI of the wrist is better than clinical, serological, or radiographic assessment at predicting long-term structural damage, an 8-year longitudinal study by researchers from the Chinese University of Hong Kong (CUHK) has shown.
